ProShare Advisors LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$283,411
-31.7%
17,669
-1.4%
0.00%0.0%
Q2 2023$415,224
+4.0%
17,913
+4.2%
0.00%0.0%
Q1 2023$399,300
+42.6%
17,189
-10.9%
0.00%0.0%
Q4 2022$280,014
-17.2%
19,298
+8.8%
0.00%0.0%
Q3 2022$338,000
+6.3%
17,744
+1.4%
0.00%0.0%
Q2 2022$318,000
-51.4%
17,494
-32.6%
0.00%0.0%
Q1 2022$654,000
-23.7%
25,954
-16.5%
0.00%
-50.0%
Q4 2021$857,000
-7.3%
31,082
+8.6%
0.00%
-33.3%
Q3 2021$924,000
-15.6%
28,627
-20.0%
0.00%0.0%
Q2 2021$1,095,000
+13.6%
35,800
+13.1%
0.00%0.0%
Q1 2021$964,000
+69.1%
31,654
+9.8%
0.00%
+50.0%
Q4 2020$570,000
+97.9%
28,820
+30.3%
0.00%
+100.0%
Q3 2020$288,000
+5.5%
22,116
-8.0%
0.00%0.0%
Q2 2020$273,000
+12.3%
24,044
+41.7%
0.00%
-50.0%
Q1 2020$243,000
-69.8%
16,965
-42.6%
0.00%
-50.0%
Q4 2019$805,000
-11.0%
29,551
-6.5%
0.00%
-20.0%
Q3 2019$904,000
-0.1%
31,591
-3.0%
0.01%0.0%
Q2 2019$905,000
-27.1%
32,582
-12.9%
0.01%
-28.6%
Q1 2019$1,242,000
+15.3%
37,423
+1.1%
0.01%
-12.5%
Q4 2018$1,077,000
-43.4%
37,033
-10.4%
0.01%
-38.5%
Q3 2018$1,902,000
+21.3%
41,350
-1.4%
0.01%
+18.2%
Q2 2018$1,568,000
+19.0%
41,946
-6.0%
0.01%
+22.2%
Q1 2018$1,318,000
-24.7%
44,600
-12.5%
0.01%
-25.0%
Q4 2017$1,751,000
+5.4%
50,969
+11.0%
0.01%
-20.0%
Q3 2017$1,662,000
+49.3%
45,928
+6.6%
0.02%
+36.4%
Q2 2017$1,113,000
+23.0%
43,079
-8.6%
0.01%
+22.2%
Q1 2017$905,000
-4.8%
47,147
-17.3%
0.01%
-18.2%
Q4 2016$951,000
-11.5%
57,022
+9.3%
0.01%
-26.7%
Q3 2016$1,074,000
-44.2%
52,170
-17.1%
0.02%
-40.0%
Q2 2016$1,925,000
-18.1%
62,917
+0.2%
0.02%
-21.9%
Q1 2016$2,350,000
-20.9%
62,786
-8.8%
0.03%
-11.1%
Q4 2015$2,971,000
+28.9%
68,831
+11.9%
0.04%
+12.5%
Q3 2015$2,305,000
-0.3%
61,491
-9.6%
0.03%0.0%
Q2 2015$2,313,000
+7.1%
68,042
+11.6%
0.03%
+28.0%
Q1 2015$2,159,000
+21.3%
60,991
+16.7%
0.02%
+19.0%
Q4 2014$1,780,000
+14.5%
52,264
+29.7%
0.02%0.0%
Q3 2014$1,554,000
-18.1%
40,298
-17.3%
0.02%
-16.0%
Q2 2014$1,897,000
-5.7%
48,741
-17.2%
0.02%0.0%
Q1 2014$2,012,000
+171.2%
58,840
+66.4%
0.02%
+127.3%
Q4 2013$742,000
+3.2%
35,360
+15.5%
0.01%
-35.3%
Q3 2013$719,000
+53.6%
30,607
+75.7%
0.02%
+88.9%
Q2 2013$468,00017,4190.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 4,000,000$45,360,0002.60%
Tieton Capital Management, LLC 166,441$1,887,0002.36%
S&T BANK/PA 315,835$3,582,0000.82%
DISCIPLINED GROWTH INVESTORS INC /MN 2,194,204$24,882,0000.60%
XTX MARKETS LLC 14,807$168,0000.57%
Glenview Capital Management 1,810,727$20,534,0000.57%
EARNEST PARTNERS LLC 4,761,082$53,991,0000.51%
AIMZ Investment Advisors, LLC 42,685$484,0000.31%
DUALITY ADVISERS, LP 163,717$1,857,0000.17%
Engineers Gate Manager LP 219,922$2,494,0000.13%
View complete list of MYRIAD GENETICS INC shareholders